Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]:
SEC Accession No. 0000912282-06-000145
Filing Date
2006-03-03
Accepted
2006-03-03 13:42:16
Documents
12
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 oncolytics_40f-12312005.htm 40-F 44081
2 ex_1.htm EX-1 320398
3 GRAPHIC fig1.jpg GRAPHIC 22867
4 GRAPHIC logo.jpg GRAPHIC 5668
5 ex_2.htm EX-2 321835
6 ex_3.htm EX-3 192761
7 ex_99a.htm EX-99.A 8389
8 ex_99b.htm EX-99.B 8407
9 ex_99c.htm EX-99.C 2716
10 ex_99d.htm EX-99.D 2786
11 ex_99e.htm EX-99.E 1442
12 ex_99f.htm EX-99.F 13086
  Complete submission text file 0000912282-06-000145.txt   956907
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 40-F | Act: 34 | File No.: 000-31062 | Film No.: 06662927
SIC: 2834 Pharmaceutical Preparations